Abstract
The advent of precise genomic targeting systems has revolutionized epigenome editing through fusion of epigenetic effector proteins with engineered DNA-binding proteins. However, the delivery of plasmid DNA to express these fusion proteins via conventional transient transfection has certain consequences which need to be considered during the experimental design. Transient transfection achieves peak gene expression between 24 and 96 h post-transfection after which the foreign gene is lost through cell division and degradation. The use of cell lines stably expressing the effector fusion protein of interest provides several advantages compared to standard transfection methods, and the most suitable means for creating these cell lines was found to be viral delivery followed by stable integration of the transgenes into the host genome. Here we describe a practical protocol to generate murine cell lines stably expressing fusion proteins of chromatin regulators and DNA-binding proteins using a retroviral murine stem cell virus (MSCV)-based vector system.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kungulovski G, Jeltsch A (2015) Epigenome editing: state of the art, concepts, and perspectives. Trends Genet 32:101–113
Siddique AN, Nunna S, Rajavelu A et al (2013) Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. J Mol Biol 425:479–491
Rivenbark AG, Stolzenburg S, Beltran AS et al (2012) Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 7:350–360
Gregory DJ, Zhang Y, Kobzik L, Fedulov AV (2013) Specific transcriptional enhancement of inducible nitric oxide synthase by targeted promoter demethylation. Epigenetics 8:1205–1212
Chen H, Kazemier HG, De Groote ML et al (2014) Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Res 42:1563–1574
Nunna S, Reinhardt R, Ragozin S, Jeltsch A (2014) Targeted methylation of the epithelial cell adhesion molecule (EpCAM) promoter to silence its expression in ovarian cancer cells. PLoS One 9(1):e87703
Keung AJ, Bashor CJ, Kiriakov S et al (2014) Using targeted chromatin regulators to engineer combinatorial and spatial transcriptional regulation. Cell 158:110–120
Kungulovski G, Nunna S, Thomas M et al (2015) Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintained. Epigenetics Chromatin 8:12
Maeder ML, Angstman JF, Richardson ME et al (2013) Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol 31:1137–1142
Cong L, Zhou RH, Kuo YC et al (2012) Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat Commun 3:968
Bernstein DL, Le Lay JE, Ruano EG, Kaestner KH (2015) TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts. J Clin Invest 125:1998–2006
Amabile A, Migliara A, Capasso P et al (2016) Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167:219–232.e14
Mendenhall EM, Williamson KE, Reyon D et al (2013) Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol 31:1133–1136
Hilton IB, D’Ippolito AM, Vockley CM et al (2015) Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33:510–517
Kearns NA, Pham H, Tabak B et al (2015) Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat Methods 12:401–403
Vojta A, Dobrinic P, Tadic V et al (2016) Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res 44:5615–5628
Danthinne X, Imperiale MJ (2000) Production of first generation adenovirus vectors: a review. Gene Ther 7:1707–1714
Wu Z, Yang H, Colosi P (2010) Effect of genome size on AAV vector packaging. Mol Ther 18:80–86
Deyle DR, Russell DW (2009) Adeno-associated virus vector integration. Curr Opin Mol Ther 11:442–447
Gélinas C, Temin HM (1986) Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc Natl Acad Sci U S A 83:9211–9215
Akkina RK, Walton RM, Chen ML et al (1996) High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 70:2581–2585
Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063–1066
Coffin JM, Hughes SH, Varmus HE (1997) Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Yu SF, von Rüden T, Kantoff PW et al (1986) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A 83:3194–3198
Gossen M, Freundlieb S, Bender G et al (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766–1769
Cherry SR, Biniszkiewicz D, van Parijs L et al (2000) Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 20:7419–7426
Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239–4242
Acknowledgments
We thank Sabine Pinter for the constructive feedback on the manuscript. The work described here was supported by the Wilhelm Sander Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kroll, C., Rathert, P. (2018). Stable Expression of Epigenome Editors via Viral Delivery and Genomic Integration. In: Jeltsch, A., Rots, M. (eds) Epigenome Editing. Methods in Molecular Biology, vol 1767. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7774-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7774-1_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7773-4
Online ISBN: 978-1-4939-7774-1
eBook Packages: Springer Protocols